AsiaTechDaily – Asia's Leading Tech and Startup Media Platform

  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • Events
    • Innovasion Exchange Programme
    • Startup Program
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
    • Unicorn interview
  • Governments
  • Events
  • Lists
  • Subscription Plan
  • Login
Menu
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • Events
    • Innovasion Exchange Programme
    • Startup Program
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
    • Unicorn interview
  • Governments
  • Events
  • Lists
  • Subscription Plan
  • Login
Submit Article
Menu
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • Events
    • Innovasion Exchange Programme
    • Startup Program
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
    • Unicorn interview
  • Governments
  • Events
  • Lists
  • Subscription Plan
  • Login
Submit Article
Join Chat 💬
Pangyo Techno Valley30 Nov 2023 6:17

Bio startups challenging the smart healthcare market in Pangyo Techno Valley

by Byungho Lim
  • twitter
Bookmark (0)
Please login to bookmark Close

No account yet? Register

Bio companies in Pangyo Techno Valley are at the forefront of industrial developments in smart healthcare, leveraging innovative technologies such as IoT and AI to stay competitive in the global market. The rise of Industry 4.0 has accelerated the growth of smart healthcare, revolutionizing the healthcare industry.

Choi Yong-jun, CEO of DooAi (left) and Eunhee Lee, Chairperson of the GC Labs (right) at the agreement signing ceremony. (Image courtesy of GC Labs)

The Pangyo Techno Valley is a hub of the fourth industrial revolution and is home to various IT and bio companies, all of which are taking an active part in the global market. DoAI (CEO: Choi Yong-jun), a company developing an early diagnosis system to detect pancreas cancer with ‘Nano-Raman Convergence Technology, has co-developed an AI-driven chromosome karyotype analysis system with GC Labs since 2022. Once developed, the system will reduce the diagnosis time by 1/10 and costs for screening agencies.

Medikinabio and the National Institute of Medical Research in Mongolia (Image courtesy of Medikinabio)

Medikinabio (CEO: Choi Woo-sung) is the first startup registered for the DEEP Tech TIPS, a private investment-oriented tech startup support program led by the Ministry of SMEs and Startups and Creative Economy Innovation Center. As a company that develops a liver cancer predicting kit, it embarks on developing a new product using biomarkers, the first kind in the nation.

Thirty out of every 100,000 people in Korea develop liver cancer, a higher rate than in other countries, and the country has the second highest cancer mortality rate. Blood tests, tissue tests, and other conventional testing methods can be time-consuming, but utilizing kits can reduce the testing time to approximately 15 minutes. Due to their cost-effectiveness, these kits are anticipated to contribute to the efficiency of liver cancer detection, potentially reducing the incidence of liver cancer. The technology has also gained recognition internationally. In October 2023, the company secured an opportunity for global growth by signing a memorandum of understanding for international collaborative clinical trials with the National Institute of Medical Research in Mongolia.

Cellico AR glasses (Image courtesy of Cellico)

The AR glasses developed by Cellico (CEO Kim Jung-seok) are also gaining recognition in the global market. In November, Celico’s augmented reality (AR) smart glasses for visually impaired patients, named EyeCane, won the CES Innovation Award in three categories following their participation in CES 2023, marking their second consecutive appearance at CES. Besides CES, they have also been recognized in the 2023 Edison Awards, solidifying their value in the global market.

Furthermore, the government is sparing no effort to support the growth of bio and medical venture startups. In May 2023, the Ministry of SMEs and Startups conducted a ‘Regulation Free Environment for Bioventure Startup’ event at Pangyo Korea Bio Park. The first topic of discussion focused on innovation startups in the health sector, considering the significant employment generation effect as a future growth engine. The event delved into discussions on six related fields, including medical devices and therapeutic devices.

In this way, startups and major companies in the bio sector of Pangyo Techno Valley have achieved various successes in the field of smart healthcare by integrating innovative technologies such as IoT and AI. They not only possess competitiveness in the domestic market but have also established a presence in the global market, thereby transforming the paradigm of the healthcare industry. It is expected that the bio companies in Pangyo Techno Valley will continue to grow and contribute to the development of the domestic bio-industry in the future.

Also Read,

  • Pangyo Techno Valley Elevates its Position in the Burgeoning Autonomous Vehicle Market, Eyeing a $55.6 Billion Opportunity
  • Pangyo Korea Biopark: South Korea’s Premier R&D Center for Biotech Firms
  • Gyeonggi Province Economic and Science Promotion Agency Facilitates Global Expansion for Pangyo Startups
  • Cellico CEO Kim Jeong-seok about Revolutionizing Vision Restoration Technology in Pangyo Techno Valley
  • Pangyo Techno Valley, a Cluster of the Korean Beauty Industry, Strengthens Its Global Competitiveness
Tags: DoAIMedikinabioPangyo Techno Valley

Similar Articles

Venture Capital12 Aug 2025 6:50

Malaysia’s Naluri Secures $5M to Grow AI-Driven Employee Wellbeing Platform

More
Venture Capital29 Jul 2025 12:59

Biotech Startup Pahr Therapeutics Raises $14M to Advance Clinical Programs for PAH

More
Venture Capital15 Jul 2025 8:00

S Korea’s Illimis Therapeutics Eyes Global Breakthroughs with $42M Series B Boost

More

Topics

Menu
  • AI & Big Data
  • AR & VR
  • Blockchain
  • Clean Technology
  • Content & Games
  • Cybersecurity
  • Enterprise & SaaS
  • Gadgets & Electronics
  • Health & Bio

Program

Menu
  • Ecosystem
  • EdTech
  • Featured
  • FinTech
  • Investments
  • IoT
  • Marketplaces & E-commerce
  • Robotics
  • Transportation & Logistics

About

Menu
  • Home
  • About us
  • Privacy Policy
  • Collaborate with AsiaTechDaily
Facebook Instagram Linkedin
  • twitter

Subscribe and be informed first hand about the actual economic news.

All the day’s headlines and highlights, direct to you every morning.

© 2023 asiatechdaily. All rights reserved.